Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: GI Dynamics, Inc.

Market Cap 4L 4L 4L 3L 6L 4.16Cr 6L 42.2L 16.35L 2.05Cr 16.53L 16.18L 7.1Cr P/E 2019
-1.12x
P/E 2020 -0.03x
Enterprise Value 32.79L 28.59L 26.48L 24.79L 46.49L 31Cr 46.78L 3.14Cr 1.22Cr 15Cr 1.23Cr 1.2Cr 53Cr EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
-
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Chief Executive Officer - 05/08/2025
Director of Finance/CFO 57 01/08/2025
Chief Tech/Sci/R&D Officer - 01/04/2023
Director TitleAgeSince
Chairman 67 21/10/2020
Director/Board Member 69 01/10/2023
Director/Board Member - 20/10/2020
Date Insider Type Main position Quantity % Market Cap.
28/21/28Free

Chief Executive Officer

1,10,75,869 3.8998%
28/21/28Free

Chairman

13,84,483 0.4875%

Financials

2019 2020
Net sales - -
Net income -1.73Cr -1.51Cr -1.4Cr -1.31Cr -2.46Cr -163.55Cr -2.47Cr -17Cr -6.44Cr -81Cr -6.51Cr -6.37Cr -279.52Cr -1.11Cr -97.09L -89.93L -84.18L -1.58Cr -105.08Cr -1.59Cr -11Cr -4.13Cr -52Cr -4.18Cr -4.09Cr -179.59Cr
Net Debt 28.87L 25.17L 23.31L 21.82L 40.93L 27Cr 41.18L 2.77Cr 1.07Cr 13Cr 1.08Cr 1.06Cr 47Cr 28.39L 24.75L 22.93L 21.46L 40.25L 27Cr 40.49L 2.72Cr 1.05Cr 13Cr 1.07Cr 1.04Cr 46Cr
Logo GI Dynamics, Inc.
GI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.
Employees
-
Sector
-
  1. Stock Market
  2. Stocks
  3. GIDYL Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!